Kenji Tokunaga
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
CD5-positive diffuse large B-Cell lymphoma presenting with protein-losing enteropathy.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: April 01, 2026
Fulminant Clostridioides difficile Infection During Repeated High-Dose Cytarabine Consolidation for Acute Myeloid Leukemia: A Fatal Case.
Journal: Cureus
Published: January 23, 2026
Chronic graft-versus-host disease manifesting as isolated myositis
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 04, 2025
Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells.
Journal: Cancer science
Published: March 05, 2023
Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome.
Journal: Clinical and translational medicine
Published: January 19, 2023
A case of primary nonleukemic myeloid sarcoma of the spleen, successfully treated by surgery and hematopoietic stem cell transplantation.
Journal: Surgical case reports
Published: May 03, 2021
A regulatory element in the 3'-untranslated region of CEBPA is associated with myeloid/NK/T-cell leukemia.
Journal: European journal of haematology
Published: October 14, 2020
RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner.
Journal: Leukemia
Published: February 09, 2020
Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.
Journal: Nature communications
Published: August 30, 2019
Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.
Journal: Nature communications
Published: April 17, 2018
Last Updated: 09/26/2026